Recovery & Tissue Repair
BPC-157, TB-500, and rehabilitation-focused peptide protocols.
About this treatment area
Recovery peptides target tissue repair, tendon and ligament healing, gut lining integrity, and inflammation. BPC-157 and TB-500 are the most requested, though both remain investigational with primarily animal-model evidence. The FDA compounding status for these peptides changed in 2026 following an advisory panel vote — check current status with your provider.
Relevant peptides
Regulatory status as of September 2026. Always confirm with your provider.
BPC-157
Research only
Gastric pentadecapeptide. Strong animal data for tendon/gut repair. Human trials limited. Compounding status changed 2026.
TB-500
Research only
Thymosin beta-4 fragment. Studied for tissue repair. WADA-banned. Compounding status changed 2026.
GHK-Cu
Compoundable
Copper peptide for wound healing and collagen synthesis. Topical and injectable forms.
KPV
Research only
Alpha-MSH fragment for gut and skin inflammation. Rodent data only.
Pentosan Polysulfate
FDA- Approved
FDA-approved as Elmiron. Used off-label for osteoarthritis.
Wolverine Stack
Research only
BPC-157 + TB-500 combination. Popular but zero combined-protocol trials.